The Impact of Ureteroscopy following Computerized Tomography Urography in the Management of Upper Tract Urothelial Carcinoma.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 17 9 2020
medline: 26 2 2021
entrez: 16 9 2020
Statut: ppublish

Résumé

We report the reliability of computerized tomography urography and ureteroscopy in the diagnosis and management of upper tract urothelial carcinoma. From 2015 to November 2018 we prospectively collected and retrospectively analyzed 244 cases of ureteroscopy with available preoperative computerized tomography urography. Computerized tomography urography was categorized as positive, suspicious, unlikely and negative. Correspondence between imaging, ureteroscopy and histology was analyzed. The therapeutic indication, based on 2020 EAU Guidelines and patient clinical data, was recorded before and after ureteroscopy. Cohen's Kappa was used for agreement analysis. Logistic regression was used for prediction of positive ureteroscopy. Ureteroscopy was positive for upper tract urothelial carcinoma in 107/115 (93%), 48/77 (62.3%), 15/27 (55.6%) and 12/25 (48%) cases with positive, suspicious, unlikely and negative computerized tomography urography, respectively. On cytohistology the result was confirmed in 164/182 (90.1%) cases. The positive predictive value of a filling defect, stenosis, thickening and hydronephrosis on computerized tomography urography was 87.7% (121/138 cases), 65.6% (21/32), 69.6% (64/92) and 79.7% (59/74), respectively. On multivariate analysis a filling defect (95% CI 2.76-11.5, OR 5.63, p <0.0001) or hydronephrosis (1.04-6.18, OR 2.52, p=0.04) was associated with ureteroscopy outcome. Among cases with positive computerized tomography urography and ureteroscopy, the lesions differed in dimensions (20/107), number (14/107) and site (11/107), for a total of 45/107 (42.1%) cases. The indication of elective treatment changed after ureteroscopy in 37/76 (48.1%) cases (Kappa=0.31), as 17/28 (60.7%), 11/20 (55%) and 11/28 (39.2%) indications were confirmed for endoscopic management, ureterectomy and nephroureterectomy, respectively. The complementary use of computerized tomography urography and ureteroscopy in the diagnostic workup of upper tract urothelial carcinoma should be evaluated.

Identifiants

pubmed: 32935620
doi: 10.1097/JU.0000000000001370
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

392-399

Commentaires et corrections

Type : CommentIn

Auteurs

Andrea Gallioli (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Department of Clinical Sciences and Community Health, University of Milan, Italy.

Angelo Territo (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.

Asier Mercadé (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.

Matteo Fontana (M)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Department of Clinical Sciences and Community Health, University of Milan, Italy.

Romain Boissier (R)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.
Aix-Marseille University, Department of Urology, APHM, La Conception Academic Hospital, Marseille, France.

Josep Maria Gaya (JM)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.

Esteban Emiliani (E)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.

Antoni Sánchez-Puy (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.

Maria José Martínez (MJ)

Fundació Puigvert, Department of Radiology, Autonomous University of Barcelona, Barcelona, Spain.

Joan Palou (J)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.

Alberto Breda (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH